Published in Sleep Med on November 01, 2002
Discharge profiles across the sleep-waking cycle of identified cholinergic, GABAergic, and glutamatergic neurons in the pontomesencephalic tegmentum of the rat. J Neurosci (2014) 1.21
Motivational activation: a unifying hypothesis of orexin/hypocretin function. Nat Neurosci (2014) 1.09
Narcolepsy: neural mechanisms of sleepiness and cataplexy. J Neurosci (2012) 1.07
Is there any point to vasovagal syncope? Clin Auton Res (2008) 0.83
Treatment paradigms for cataplexy in narcolepsy: past, present, and future. Nat Sci Sleep (2015) 0.79
Proven cardiac changes during death-feigning (tonic immobility) in rabbits (Oryctolagus cuniculus). J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2014) 0.78
Using magnetic resonance spectroscopy in narcolepsy to study the limbic mechanisms of cataplexy. Sleep (2009) 0.75
Cataplexy: 'REM-atonia or tonic immobility'? Sleep Med (2002) 0.75
Shining evolutionary light on human sleep and sleep disorders. Evol Med Public Health (2016) 0.75
Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J (2009) 8.25
The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol (2002) 4.03
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res (2011) 3.88
Guidelines on management (diagnosis and treatment) of syncope--update 2004. Europace (2004) 2.47
Hypocretin (orexin) loss in Parkinson's disease. Brain (2007) 1.98
A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab (2010) 1.98
Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke (2006) 1.93
Startle syndromes. Lancet Neurol (2006) 1.93
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci (2011) 1.82
The "posture second" strategy: a review of wrong priorities in Parkinson's disease. J Neurol Sci (2006) 1.78
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol (2013) 1.71
ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet (2013) 1.55
Natural history of obstetric brachial plexus palsy: a systematic review. Dev Med Child Neurol (2004) 1.46
Hypocretin/orexin disturbances in neurological disorders. Sleep Med Rev (2008) 1.45
Intraoperative nerve action and compound motor action potential recordings in patients with obstetric brachial plexus lesions. J Neurosurg (2008) 1.43
Extensive motor axonal misrouting after conservative treatment of obstetric brachial plexus lesions. Dev Med Child Neurol (2014) 1.41
The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine (2012) 1.41
Narcolepsy: immunological aspects. Sleep Med Rev (2008) 1.28
Symptoms and signs of syncope: a review of the link between physiology and clinical clues. Brain (2009) 1.27
Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS. J Clin Oncol (2011) 1.21
Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity. Obes Res (2003) 1.19
Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease. Parkinsonism Relat Disord (2010) 1.18
Partial sleep restriction decreases insulin sensitivity in type 1 diabetes. Diabetes Care (2010) 1.14
Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia. Gen Hosp Psychiatry (2009) 1.06
Hypocretin (orexin) loss in Alzheimer's disease. Neurobiol Aging (2011) 1.05
Altered skin-temperature regulation in narcolepsy relates to sleep propensity. Sleep (2006) 1.05
Focusing on vigilance instead of sleepiness in the assessment of narcolepsy: high sensitivity of the Sustained Attention to Response Task (SART). Sleep (2006) 1.04
Is motor inhibition during laughter due to emotional or respiratory influences? Psychophysiology (2004) 1.02
The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency. Sleep Med (2010) 0.99
Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls. Am J Physiol Endocrinol Metab (2011) 0.99
Increased heart rate variability but normal resting metabolic rate in hypocretin/orexin-deficient human narcolepsy. J Clin Sleep Med (2008) 0.99
Neural dynamics during anoxia and the "wave of death". PLoS One (2011) 0.98
Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse rolling Nagoya. Eur J Neurosci (2007) 0.97
The effects of cortisol administration on approach-avoidance behavior: an event-related potential study. Biol Psychol (2007) 0.97
Reward-seeking behavior in human narcolepsy. J Clin Sleep Med (2011) 0.96
The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome. J Clin Endocrinol Metab (2005) 0.95
Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation. Vaccine (2012) 0.93
Assessment of sleep and sleepiness in Parkinson disease. Sleep (2003) 0.93
Electromyography, nerve action potential, and compound motor action potentials in obstetric brachial plexus lesions: validation in the absence of a "gold standard". Neurosurgery (2009) 0.92
Falls, faints, fits and funny turns. J Neurol (2009) 0.91
Respiratory countermaneuvers in autonomic failure. Neurology (2007) 0.89
Manipulation of core body and skin temperature improves vigilance and maintenance of wakefulness in narcolepsy. Sleep (2008) 0.88
The semiology of tilt-induced psychogenic pseudosyncope. Neurology (2013) 0.88
Syncope. Curr Probl Cardiol (2004) 0.88
Possible confusion between primary hypersomnia and adult attention-deficit/hyperactivity disorder. Psychiatry Res (2006) 0.88
Choice reaction times for human head rotations are shortened by startling acoustic stimuli, irrespective of stimulus direction. J Physiol (2007) 0.87
Voxel-based morphometry in hypocretin-deficient narcolepsy. Sleep (2003) 0.87
Anti-Ri antibody positive opsoclonus-myoclonus in a male patient with breast carcinoma. J Neurol (2002) 0.87
Unconscious confusion--a literature search for definitions of syncope and related disorders. Clin Auton Res (2005) 0.86
Major and minor form of hereditary hyperekplexia. Mov Disord (2002) 0.86
Association between hypocretin-1 and amyloid-β42 cerebrospinal fluid levels in Alzheimer's disease and healthy controls. Curr Alzheimer Res (2012) 0.85
Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy. Curr Opin Neurol (2002) 0.84
Syncope Unit: rationale and requirement - the European Heart Rhythm Association position statement endorsed by the Heart Rhythm Society. Europace (2015) 0.84
Narcolepsy and pregnancy: a retrospective European evaluation of 249 pregnancies. J Sleep Res (2013) 0.84
Status vasovagalis. Lancet (2009) 0.83
Sustained attention to response task (SART) shows impaired vigilance in a spectrum of disorders of excessive daytime sleepiness. J Sleep Res (2011) 0.83
Is there any point to vasovagal syncope? Clin Auton Res (2008) 0.83
Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy. J Neurol (2007) 0.82
Neurophysiologic aspects of patients with generalized or multifocal tonic dystonia of reflex sympathetic dystrophy. J Clin Neurophysiol (2002) 0.82
Spatiotemporal integration of sensory stimuli in complex regional pain syndrome and dystonia. J Neural Transm (Vienna) (2009) 0.82
Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy. J Neuroimmunol (2006) 0.82
Too many solutions for one problem. Muscle Nerve (2006) 0.81
Altered setting of the pituitary-thyroid ensemble in hypocretin-deficient narcoleptic men. Am J Physiol Endocrinol Metab (2004) 0.81
Severe fatigue in narcolepsy with cataplexy. J Sleep Res (2011) 0.81
Severe obstetric brachial plexus palsies can be identified at one month of age. PLoS One (2011) 0.81
Time- and state-dependent analysis of autonomic control in narcolepsy: higher heart rate with normal heart rate variability independent of sleep fragmentation. J Sleep Res (2014) 0.80
Hypernatremia from a hunger strike as a cause of osmotic myelinolysis. Neurology (2005) 0.80
Water drinking as a potential treatment for idiopathic exercise-related syncope: a case report. Clin Auton Res (2003) 0.80
Corticospinal excitability during laughter: implications for cataplexy and the comparison with REM sleep atonia. J Sleep Res (2004) 0.79
CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2009) 0.79
Hypocretin (orexin) loss and sleep disturbances in Parkinson's Disease. Brain (2007) 0.79
Assessment of human sleep depth is being de-standardized by recently advised EEG electrode locations. PLoS One (2013) 0.79
Are the orthostatic fluid shifts to the calves augmented in autonomic failure? Clin Auton Res (2009) 0.79
Syncope in adults: terminology, classification, and diagnostic strategy. Pacing Clin Electrophysiol (2006) 0.78
The influences of task repetition, napping, time of day, and instruction on the Sustained Attention to Response Task. J Clin Exp Neuropsychol (2014) 0.78
Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events. Am J Physiol Endocrinol Metab (2002) 0.78
Syncope and orthostatic intolerance increase risk of brain lesions in migraineurs and controls. Neurology (2013) 0.78
Assessment of orthostatic fluid shifts with strain gauge plethysmography. Clin Sci (Lond) (2007) 0.78
Plasma total ghrelin and leptin levels in human narcolepsy and matched healthy controls: basal concentrations and response to sodium oxybate. J Clin Sleep Med (2013) 0.78
EEG markers of future cognitive performance in the elderly. J Clin Neurophysiol (2008) 0.77
Re: Silber MH, Krahn LE, Olson EJ. Diagnosing narcolepsy: validity and reliability of new diagnostic criteria. Sleep Med. 2002 Mar;3(2):109-13. Sleep Med (2002) 0.77
Longitudinal pilot-study of Sustained Attention to Response Task and P300 in manifest and pre-manifest Huntington's disease. J Neuropsychol (2013) 0.76
Sodium oxybate is an effective and safe treatment for narcolepsy. Sleep Med (2009) 0.76
Contrasting effects of isocapnic and hypocapnic hyperventilation on orthostatic circulatory control. J Appl Physiol (1985) (2008) 0.76
Sodium oxybate increases prolactin secretion in narcolepsy patients and healthy controls. Eur J Endocrinol (2010) 0.76
Cataplexy leading to the diagnosis of Niemann-Pick disease type C. Pediatr Neurol (2006) 0.76
Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy. Neurosci Lett (2003) 0.76
Cortisol-induced enhancement of emotional face processing in social phobia depends on symptom severity and motivational context. Biol Psychol (2009) 0.76
Altered circadian rhythm of melatonin concentrations in hypocretin-deficient men. Chronobiol Int (2012) 0.76
A DC attenuator allows common EEG equipment to record fullband EEG, and fits fullband EEG into standard European Data Format. Clin Neurophysiol (2010) 0.76
Thermal hypesthesia in patients with complex regional pain syndrome related dystonia. J Neural Transm (Vienna) (2010) 0.76
Heart rate variability testing, or listening to a conversation in a foreign language. Clin Auton Res (2003) 0.75
Case 26-2005: loss of consciousness while jogging. N Engl J Med (2006) 0.75